Fragment Binding to the Nsp3 Macrodomain of SARS-CoV-2 Identified Through Crystallographic Screening and Computational Docking
Author:
Schuller MarionORCID, Correy Galen J.ORCID, Gahbauer StefanORCID, Fearon DarenORCID, Wu TaiaseanORCID, Díaz Roberto EfraínORCID, Young Iris D.ORCID, Martins Luan CarvalhoORCID, Smith Dominique H., Schulze-Gahmen UrsulaORCID, Owens Tristan W.ORCID, Deshpande IshanORCID, Merz Gregory E.ORCID, Thwin Aye C.ORCID, Biel Justin T.ORCID, Peters Jessica K.ORCID, Moritz MichelleORCID, Herrera NadiaORCID, Kratochvil Huong T.ORCID, Aimon AnthonyORCID, Bennett James M.ORCID, Neto Jose BrandaoORCID, Cohen Aina E.ORCID, Dias AlexandreORCID, Douangamath AliceORCID, Dunnett LouiseORCID, Fedorov OlegORCID, Ferla Matteo P.ORCID, Fuchs MartinORCID, Gorrie-Stone Tyler J.ORCID, Holton James M.ORCID, Johnson Michael G., Krojer TobiasORCID, Meigs George, Powell Ailsa J.ORCID, Rack Johannes Gregor MatthiasORCID, Rangel Victor LORCID, Russi SilviaORCID, Skyner Rachael E.ORCID, Smith Clyde A.ORCID, Soares Alexei S.ORCID, Wierman Jennifer L.ORCID, Zhu KangORCID, Jura NataliaORCID, Ashworth AlanORCID, Irwin JohnORCID, Thompson Michael C.ORCID, Gestwicki Jason E.ORCID, von Delft FrankORCID, Shoichet Brian K.ORCID, Fraser James S.ORCID, Ahel IvanORCID,
Abstract
ABSTRACTThe SARS-CoV-2 macrodomain (Mac1) within the non-structural protein 3 (Nsp3) counteracts host-mediated antiviral ADP-ribosylation signalling. This enzyme is a promising antiviral target because catalytic mutations render viruses non-pathogenic. Here, we report a massive crystallographic screening and computational docking effort, identifying new chemical matter primarily targeting the active site of the macrodomain. Crystallographic screening of diverse fragment libraries resulted in 214 unique macrodomain-binding fragments, out of 2,683 screened. An additional 60 molecules were selected from docking over 20 million fragments, of which 20 were crystallographically confirmed. X-ray data collection to ultra-high resolution and at physiological temperature enabled assessment of the conformational heterogeneity around the active site. Several crystallographic and docking fragment hits were validated for solution binding using three biophysical techniques (DSF, HTRF, ITC). Overall, the 234 fragment structures presented explore a wide range of chemotypes and provide starting points for development of potent SARS-CoV-2 macrodomain inhibitors.
Publisher
Cold Spring Harbor Laboratory
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|